ClinicalTrials.Veeva

Menu

Metabolomic Study in Exhaled Breath Condensate of Thoracic Surgical Patients

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Acute Pulmonary Insufficiency Following Thoracic Surgery
Ventilator-associated Lung Injury

Treatments

Procedure: Thoracic Surgery with Lung Resection
Procedure: Thoracic Surgery without Lung Resection

Study type

Observational

Funder types

Other

Identifiers

NCT02583984
201505133RINC

Details and patient eligibility

About

Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC for metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.

Full description

Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. Despite the advancement in both the surgical techniques and the perioperative management, the incidence of postoperative ALI remains remarkable. Risk factors for postoperative lung injury are evident, including preoperative pulmonary function, type of surgical procedure, intraoperative fluid management, one-lung ventilation, and ventilator settings. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. EBC analysis has potential applications in lung disease, such as severity of airway inflammation in asthmatic patients. Collecting EBC is simple and non-invasive, in contrast to bronchoscopy for lung biopsy or bronchoalveolar lavage. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC from thoracic surgical patients before, during, and after OLV. The investigators will perform metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.

Enrollment

40 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Thoracic surgical patients requiring lung isolation
  • Pulmonary resection: lobectomy, segmentectomy
  • Esophageal surgery and no pulmonary resection
  • Mediastinal surgery and no pulmonary resection

Exclusion criteria

  • Metabolic disorder
  • Metabolic syndrome
  • Diabetes
  • Pregnancy

Trial design

40 participants in 2 patient groups

Thoracic Surgery with Lung Resection
Description:
General anesthesia and lung separation Thoracic Surgery with Lung Resection, such as lobectomy, segmentectomy
Treatment:
Procedure: Thoracic Surgery with Lung Resection
Thoracic Surgery without Lung Resection
Description:
General anesthesia and lung separation Thoracic Surgery without Lung Resection, such as esophageal surgery, mediastinal surgery
Treatment:
Procedure: Thoracic Surgery without Lung Resection

Trial contacts and locations

1

Loading...

Central trial contact

Ya-Jung Cheng, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems